Skip to main content
Careers
Contact us
Company
About Us
Management
Board of Directors
Advisory Board
Therapeutic Focus
Neurological Disorders
Chronic Pain
Hair Loss Disorders
Science and Technology
Exicure's Approach
References and Papers
Pipeline
Pipeline
Collaboration Programs
Partnering and Licensing
Investors
Investors
News
Events & Presentations
Stock Info
Stock Quote & Chart
Analyst Coverage
Form 8937
Financials
Interactive Financials
Financial Summary
SEC Filings
Annual Reports
Governance
Executive Management
Board of Directors
Governance Documents
Committee Composition
Resources
Contact IR
FAQs
Email Alerts
News
Company
About Us
Management
Board of Directors
Advisory Board
Scientific Team
Therapeutic Focus
Genetic Disorders
Oncology
Science and Technology
Pipeline
Pipeline
AST-008
XCUR-FXN
Collaboration Programs
Compassionate Use Policy
Partnering and Licensing
Investors
Investors
News
Events & Presentations
Stock Info
Stock Quote & Chart
Analyst Coverage
Form 8937
Financials
Interactive Financials
Financial Summary
SEC Filings
Annual Reports
Governance
Executive Management
Board of Directors
Governance Documents
Committee Composition
Resources
Contact IR
FAQs
Email Alerts
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
12/23/2019
Exicure Announces the Closing of its Offering of Common Stock
Download
PDF format download (opens in new window)
12/19/2019
Exicure Announces Pricing of $27.5 Million Public Offering of Common Stock
Download
PDF format download (opens in new window)
12/18/2019
Exicure Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
12/16/2019
Exicure Announces First Neurological Development Program in Friedreich’s Ataxia and Expands Scientific Advisory Board
Download
PDF format download (opens in new window)
12/11/2019
Exicure Reports Activity of AST-008 in Patients with Merkel Cell Carcinoma and Will Enroll Patients in Phase 2 Study
Download
PDF format download (opens in new window)
11/14/2019
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
Download
PDF format download (opens in new window)
11/13/2019
Exicure’s CEO David Giljohann Honored in Crain’s 40 Under 40 Class of 2019
Download
PDF format download (opens in new window)
11/07/2019
Exicure Reports Third Quarter 2019 Financial Results and Recent Developments
Download
PDF format download (opens in new window)
10/21/2019
Exicure to Present at 2019 BIO Investor Forum
Download
PDF format download (opens in new window)
10/16/2019
Exicure Presents Positive Biomarker Results from Clinical Trial of XCUR17
Download
PDF format download (opens in new window)
10/14/2019
Exicure to Present Clinical Results from XCUR17 at the 15th Annual Meeting of the Oligonucleotide Therapeutics Society
Download
PDF format download (opens in new window)
09/17/2019
Exicure to Present at 2019 International Oligonucleotide and Peptide Conference
Download
PDF format download (opens in new window)
09/03/2019
Exicure to Present at Upcoming Investor Conferences
Download
PDF format download (opens in new window)
08/08/2019
Exicure Reports Second Quarter 2019 Financial Results and Recent Developments
Download
PDF format download (opens in new window)
08/07/2019
Exicure Appoints Dr. Bali Muralidhar of Abingworth LLP and Bosun Hau of Tybourne Capital Management to its Board of Directors
Download
PDF format download (opens in new window)
08/02/2019
Exicure Announces the Closing of its Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Download
PDF format download (opens in new window)
07/31/2019
Exicure Announces Uplisting to Nasdaq Capital Market and Pricing of $55 Million Public Offering of Common Stock
Download
PDF format download (opens in new window)
07/30/2019
Exicure Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
Download
PDF format download (opens in new window)
07/22/2019
Exicure Appoints Jeffrey L. Cleland and Tim Walbert to Board of Directors
Download
PDF format download (opens in new window)
07/11/2019
Exicure Co-Founder Chad Mirkin Wins Kabiller Prize in Nanoscience and Nanomedicine
Download
PDF format download (opens in new window)
06/26/2019
Exicure Announces Preclinical Data Supporting Development of SNA Technology in the Central Nervous System
Download
PDF format download (opens in new window)
06/03/2019
Exicure to Present at LD Micro 9th Invitational Conference
Download
PDF format download (opens in new window)
05/22/2019
Exicure to Present at TIDES 2019 on Preclinical and Clinical Development of AST-008
Download
PDF format download (opens in new window)
05/09/2019
Exicure to Present Poster at SID 2019 Annual Meeting Demonstrating Bi-Specific Gene Targeting in Dermatology
Download
PDF format download (opens in new window)
05/08/2019
Exicure, Inc. Reports First Quarter 2019 Financial Results and Reviews Corporate Progress
Download
PDF format download (opens in new window)
05/03/2019
Exicure to Present Poster at AAN 2019
Download
PDF format download (opens in new window)
04/30/2019
Exicure to Present Poster at ARVO 2019
Download
PDF format download (opens in new window)
04/01/2019
Exicure to Present at H.C. Wainwright Global Life Sciences Conference 2019
Download
PDF format download (opens in new window)
04/01/2019
Exicure to Present at the AACR Annual Meeting 2019
Download
PDF format download (opens in new window)
03/26/2019
Exicure to Present at Spring Investor Summit 2019
Download
PDF format download (opens in new window)
03/08/2019
Exicure, Inc. Reports Full Year 2018 Financial Results and Corporate Progress
Download
PDF format download (opens in new window)
02/25/2019
Exicure Announces Dosing of First Patient in Phase 1b/2 Immuno-oncology Trial
Download
PDF format download (opens in new window)
02/21/2019
Exicure to Present at the 12th Annual European Life Sciences CEO Forum
Download
PDF format download (opens in new window)
02/19/2019
Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases
Download
PDF format download (opens in new window)
02/18/2019
Exicure to Present at SMi’s RNA Therapeutics 2019 Conference
Download
PDF format download (opens in new window)
02/06/2019
Exicure to Present at BIO CEO & Investor Conference 2019
Download
PDF format download (opens in new window)
02/05/2019
Exicure Announces US Clinical Sites for Phase 1b/2 Oncology Trial
Download
PDF format download (opens in new window)
02/04/2019
Exicure to Present at the Immuno-Oncology 360° Conference
Download
PDF format download (opens in new window)
01/03/2019
Exicure to Present at Biotech Showcase 2019 on January 8th at 2:30 pm PT
Download
PDF format download (opens in new window)